Illness trajectories of incurable solid cancers
This article discusses the evolving treatment trajectories for patients with incurable solid cancers, focusing on the impact of newer systemic anticancer treatments, such as immunotherapy and targeted therapy. The updated trajectories now include major temporary improvement, long term ongoing response, rapid decline due to adverse events, and the traditional trajectory. The importance of discussing patients’…